---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-032705"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:31:45.662495+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "medium"
source: SEC EDGAR
---

# NRx subsidiary HOPE signs non-binding LOI to acquire Florida Interventional Psychiatry Clinics

## Summary
- HOPE Therapeutics, NRx subsidiary, signs LOI for first Interventional Psychiatry Clinics in Florida.
- Clinics are revenue generating and EBITDA positive; acquisition expected to be immediately accretive.
- Acquisition subject to definitive documentation and receipt of adequate financing.
- Clinics will form foundation for HOPE's growth in Florida; founders to help optimize additional acquisitions.
- NRx and HOPE aim to establish a model for CNS care clinics nationwide.

## SEC filing metadata
- accession: 0001437749-24-032705
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: medium
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000143774924032705/0001437749-24-032705-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000143774924032705/nrxp20241031_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-032705
- JSON: https://secwatch.observer/filing/0001437749-24-032705.json
- Plain text: https://secwatch.observer/filing/0001437749-24-032705.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.